 |
 |

Improvement of High-Density Lipoprotein-Cholesterol LevelsAmbulatory Type I Diabetics Treated With the Subcutaneous Insulin Pump
James M. Falko, MD;
Thomas M. O'Dorisio, MD;
Samuel Cataland, MD
JAMA. 1982;247(1):37-39.
Abstract
 |  |
Twelve ambulatory patients (six women and six men; mean age, 29 years) with type I diabetes were treated with a continuous subcutaneous open-loop insulin pump in an attempt to effect better glucose control. Hemoglobin A1, mean blood glucose, total cholesterol, total triglycerides, low-density lipoprotein-cholesterol (LDL-C), high-density lipoprotein-cholesterol (HDL-C), and the cholesterol/HDL-C ratio were assessed monthly before and after glucoregulation from five to 14 months (mean, nine months). Mean HDL-C levels increased significantly (52±4 to 60±5 mg/dL); mean cholesterol/HDL-C ratios decreased significantly (4.46±0.43 to 3.89±0.39). Mean values for triglycerides, total cholesterol, and LDL-C, all initially normal, did not change. Both mean Hb A1 levels and glucose levels fell from 11.2%±0.5% to 9.8%±0.5% and 177±15 mg/dL to 128±12 mg/dL, respectively. Insulin requirements decreased from 0.80±0.08 to 0.61±0.05 units/ kg/24 hr. These results may favorably alter the prediction for development of accelerated atherosclerosis in type I diabetics.
(JAMA 1982;247:37-39)
Author Affiliations
From the Department of Medicine, Ohio State University Hospitals, Columbus.
Footnotes
Reprint requests to Ohio State University Hospitals, 410 W Tenth Ave, Room N-1111, Columbus, OH 43210 (Dr Falko).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Continuous Subcutaneous Insulin Infusion: A Comprehensive Review of Insulin Pump Therapy
Lenhard and Reeves
Arch Intern Med 2001;161:2293-2300.
ABSTRACT
| FULL TEXT
Prevalence and Phenotypic Distribution of Dyslipidemia in Type 1 Diabetes Mellitus: Effect of Glycemic Control
Perez et al.
Arch Intern Med 2000;160:2756-2762.
ABSTRACT
| FULL TEXT
|